Newsroom

Sorted by: Latest

-

OrganaBio Acquires Excellos Operating Assets, Establishing a Coast-to-Coast Cell Therapy Contract Testing, Development and Manufacturing Organization

MIAMI--(BUSINESS WIRE)--OrganaBio, LLC ("OrganaBio"), a manufacturer of GMP cells and blood products and provider of cell isolation and cryopreservation services, has acquired substantially all of the operating assets of San Diego-based Excellos Inc. to create a bicoastal cell therapy contract development and manufacturing organization. Newly formed OrganaBio subsidiary Excellos Labs, LLC (“Excellos Labs”) will be responsible for San Diego operations going forward. The acquisition creates a mor...
-

Azelis: Results of the General Meeting 2026 & Dividend Payment Details

ANTWERP, Belgium--(BUSINESS WIRE)--Regulatory News: Azelis (Brussels:AZE), the reference innovation service provider in the speciality chemical and food ingredients industry, today held its Annual General Meeting (“AGM”) followed by an Extraordinary General Meeting (“EGM”) in Antwerp, Belgium. At the AGM and EGM of Azelis Group NV (the “Company”), 81.09 % of all shares entitled to vote were represented. The AGM approved for the fiscal year 2025 the payment of a gross dividend of € 0.226 per sha...
-

Poxel : nombre d’actions et de droits de vote composant le capital social

LYON, France--(BUSINESS WIRE)--Regulatory News: Poxel (Paris:POXEL): Conformément aux dispositions de l’article L.233-8 II du Code de Commerce et de l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers (« AMF »). Date Nombre total d’actions composant le capital Nombre total de droits de vote bruts Nombre total de droits de vote exerçables1 30 avril 2026 61 158 167 61 158 167 61 062 998 Toute l’information est disponible sur le site web www.poxelpharma.com, rubrique Investi...
-

Azelis: Resultaten van de algemene vergadering van aandeelhouders 2026 & details dividendbetaling

ANTWERP, Belgium--(BUSINESS WIRE)--Koersgevoelige Informatie: Azelis (Brussels:AZE), de toonaangevende leverancier van innovatiediensten in speciale chemicaliën en voedingsingrediënten, hield vandaag haar gewone algemene vergadering (“AV”), gevolgd door een buitengewone algemene vergadering (“BAV”) in Antwerpen, België. Op de AV en BAV van Azelis Group NV (de “Vennootschap”) waren 81,09 % van alle stemgerechtigde aandelen vertegenwoordigd. De AV keurde voor boekjaar 2025 de betaling goed van ee...
-

Rudolph and Sletten Awarded Contract for Sutter’s Advanced Orthopedics & Sports Medicine Care Complex

MENLO PARK, Calif.--(BUSINESS WIRE)--Tutor Perini Corporation (NYSE: TPC) (the “Company”), a leading civil, building and specialty construction company, announced today that its subsidiary, Rudolph and Sletten, has been awarded a contract by Sutter Health for its future Advanced Orthopedics & Sports Medicine Care Complex in Sacramento, California. The project scope of work includes the conversion of the existing 660 J Street office building into a new approximately 120,000 square-foot ambul...
-

Aelis Farma: Combined General Meeting of June 3, 2026: Availability of Preparatory Documents and Participation and Voting Procedures

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain and peripheral diseases involving the CB1 receptor, informs its shareholders and the financial community that the Company’s Combined General Meeting will be held on Wednesday, June 3, 2026, at 2 p.m., at IECB, 2 rue Robert Escarpit, 33607 Pessac. The notice of the meeting, including the agenda and...
-

Aelis Farma - Assemblée générale mixte du 3 juin 2026 : Mise à disposition des documents préparatoires et modalités de participation et de vote

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements des maladies cérébrales et périphériques impliquant le récepteur CB1, informe ses actionnaires et l’ensemble de la communauté financière que l’assemblée générale mixte de la Société se tiendra le mercredi 3 juin 2026 à 14 heures, à l’IECB, 2 rue Robert Escarpit, 33607 Pessac. L’a...
-

Spritz Selects Modern Treasury to Unify Multi-Rail Consumer Payments

SAN FRANCISCO--(BUSINESS WIRE)--Modern Treasury today announced that Spritz, the premium crypto app for real-world spending, has selected Modern Treasury to power its fiat and stablecoin payment infrastructure. Spritz enables consumers to seamlessly spend, move, and manage funds across bank accounts and crypto by bridging traditional payment systems and blockchain networks in a single experience. To deliver on this vision, Spritz needed infrastructure capable of reliably supporting both fiat an...
-

36 Years of Cluen: Pushing the Boundaries of Executive Search Technology

NEW YORK--(BUSINESS WIRE)--Cluen, a world leader in executive search technology, commemorates its latest milestone with over three decades of innovation, partnership, and leadership in the industry. Cluen has provided executive search companies, internal talent teams, and advisors with software that adapts to the industry's most demanding requirements since 1990. Encore is Cluen's AI-Powered recruitment platform that empowers search teams on six continents–starting as a vision for relationship-...
-

Lone Star Funds Announces Sale of Premier Palm Beach Gardens Retail Center

DALLAS & NEW YORK & LONDON & TOKYO--(BUSINESS WIRE)--Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Real Estate Fund VI, L.P. has successfully completed the sale of Legacy Place, a 419,936-square-foot regional retail center located in Palm Beach Gardens, FL, to real estate investor DLC, an owner/operator of open-air retail real estate. Lone Star originally purchased the property in 2021, recognizing an opportunity to acquire a high-quality Class A retail property i...